Simplify Logo

Full-Time

Senior Manager

Medical Affairs, Congress Planning, Temporary

Posted on 6/14/2024

Vir Biotechnology

Vir Biotechnology

501-1,000 employees

Develops treatments for infectious diseases

Biotechnology
Healthcare

Compensation Overview

$138k - $190kAnnually

Senior, Expert

San Francisco, CA, USA

This is an onsite position in our San Francisco headquarters.

Category
Project Management
Business & Strategy
Requirements
  • Bachelor's degree from an accredited college in the US or equivalent
  • 5+ years of experience in congress management, knowledge of pharmaceutical congress industry, codes and practices in US and EU
  • Demonstrated experience working with external suppliers and virtual and hybrid events
  • Knowledge of global pharmaceutical market and understanding of external partners including physicians, payers and patients
  • National and international travel
Responsibilities
  • Provide conference project management, including logistics, meeting space, hotel reservations (housing block), conference registrations, travel arrangements, special events at congresses, such as dinners and advisory boards
  • Be the relationship manager to external agencies, including Professional Medical Associations
  • Maintain and follow Vir's standard operating procedures relating to medical affairs
  • Contracting (advisors, agencies, sponsorships)
  • Oversee congress/conference budgets and reconciliations
  • Promote innovation, value generation, and share best practice across all departments
  • Advise senior leaders across all departments on meetings and events strategy
  • Support capability development of congress and conference planning
  • Ensure success of virtual/hybrid digital transformation and delivery with an understanding of Security and Digital Assessments policies

Vir Biotechnology is at the forefront of combating infectious diseases, leveraging advanced technologies such as a proprietary monoclonal antibody platform along with machine learning and artificial intelligence. This focus not only prioritizes public health but also fosters a culture of continuous innovation and commitment to scientific excellence. Working here means contributing to pivotal developments that address some of the most pressing global health challenges today, such as influenza, HIV, and COVID-19, in an environment that values cutting-edge research and a collaborative spirit.

Company Stage

Grant

Total Funding

$908.6M

Headquarters

San Francisco, California

Founded

2016

Growth & Insights
Headcount

6 month growth

1%

1 year growth

2%

2 year growth

9%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent bullish quarterly reports and increased analyst estimates suggest strong financial performance.
  • Significant investments, such as the $214,000 from Diversified Trust Co, indicate confidence in Vir's future prospects.
  • Presentations at high-profile conferences like J.P. Morgan's Annual Healthcare Conference and AASLD's The Liver Meeting® enhance Vir's visibility and credibility in the biotech community.

What critics are saying

  • Recent layoffs and facility shutdowns indicate potential financial instability and operational challenges.
  • The resignation of key executives, including the CFO and Chief Medical Officer, could lead to strategic and leadership uncertainties.

What makes Vir Biotechnology unique

  • Vir Biotechnology's focus on leveraging immunology expertise to engineer human antibodies into powerful medicines sets it apart from competitors.
  • Their rapid growth, as evidenced by being ranked the fastest-growing company in North America on the 2023 Deloitte Technology Fast 500, highlights their market impact.
  • Vir's ongoing Phase 2 trials for chronic hepatitis delta and B demonstrate their commitment to addressing unmet medical needs with innovative therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement

INACTIVE